Doctor profile · Federal record
Dr. ERIK KOKKONEN, M.D.
Dermatology Physician (CMS: DERMATOLOGY) · SALEM, OR
- NPI 1497019905
- Accepts Medicare
- MIPS 100.0 / 100 · 2023
- 14 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
2441 GREAR ST NE
SALEM, OR 973012749
(503) 588-0469
fax (503) 566-2063
Credentials & registration
- NPI registered
- June 2012 — 14 yrs on file
- Profile last updated
- November 8, 2016
- Year of graduation
- 2012 — 14 yrs since
- Specialty taxonomy
- 207N00000X — NUCC code
- State license (1)
- Illinois #125061642
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1497019905. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
4,706
Distinct HCPCS
10
Medicare allowed
$244,022
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
17003 |
Destruction of precancer skin growth, 2-14 growths | 2,033 | 368 | $7 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 689 | 500 | $88 | |
17000 |
Destruction of precancer skin growth, 1 growth | 598 | 451 | $53 | |
11102 |
Biopsy of related skin growth, first growth | 281 | 237 | $96 | |
96900 |
Application of ultraviolet light to skin | 223 | 24 | $24 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 222 | 175 | $124 | |
99203 |
New patient office or other outpatient visit, 30-44 minutes | 180 | 180 | $109 | |
17110 |
Destruction of skin growth, 1-14 growths | 114 | 105 | $108 | |
11103 |
Biopsy of related skin growth, each additional growth | 80 | 55 | $49 | |
17004 |
Destruction of precancer skin growth, 15 or more growths | 65 | 52 | $166 |
In context: peer comparison
Among 7 peers in this city , average services per provider: 412. This provider delivers 11× the peer median.Open Payments
Industry payments received
All-time total
$1,375
Transactions
69
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| ABBVIE INC. | 10 | $259.07 | |
| E.R. Squibb & Sons, L.L.C. | 18 | $216.35 | |
| Janssen Biotech, Inc. | 9 | $155.54 | |
| Dermavant Sciences, Inc. | 7 | $132.58 | |
| PFIZER INC. | 5 | $106.49 | |
| Incyte Corporation | 4 | $84.31 | |
| Organon Llc | 3 | $72.12 | |
| Amgen Inc. | 2 | $60.13 | |
| Novartis Pharmaceuticals Corporation | 3 | $59.83 | |
| Lilly USA, LLC | 3 | $58.65 | |
| Elekta, Inc. | 1 | $51.59 | |
| Regeneron Healthcare Solutions, Inc. | 1 | $39.02 | |
| GENZYME CORPORATION | 1 | $37.36 | |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $27.12 | |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $15.07 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
816
Patients
522
Total drug cost
$115,775
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Clobetasol Propionate | Generic | 238 | 146 | $13,132 |
| Triamcinolone Acetonide | Generic | 128 | 103 | $1,275 |
| Ketoconazole | Generic | 88 | 62 | $2,153 |
| Doxycycline Hyclate | Generic | 47 | 25 | $2,493 |
| Metronidazole | Generic | 41 | 30 | $2,162 |
| Doxycycline Monohydrate | Generic | 37 | 23 | $781 |
| Clindamycin Phosphate | Generic | 36 | 21 | $2,437 |
| Ciclopirox | Generic | 33 | 21 | $1,537 |
| Hydrocortisone | Generic | 32 | 26 | $193 |
| Fluorouracil | Generic | 27 | 25 | $2,139 |